A detailed history of Ubs Group Ag transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ubs Group Ag holds 91,494 shares of PRCT stock, worth $8.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,494
Previous 69,595 31.47%
Holding current value
$8.48 Million
Previous $4.25 Million 72.41%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $1.23 Million - $1.86 Million
21,899 Added 31.47%
91,494 $7.33 Million
Q2 2024

Aug 13, 2024

BUY
$45.73 - $69.19 $765,931 - $1.16 Million
16,749 Added 31.69%
69,595 $4.25 Million
Q1 2024

May 13, 2024

BUY
$40.38 - $50.75 $815,877 - $1.03 Million
20,205 Added 61.9%
52,846 $2.61 Million
Q4 2023

Feb 09, 2024

BUY
$24.89 - $43.41 $726,912 - $1.27 Million
29,205 Added 849.97%
32,641 $1.37 Million
Q3 2023

Nov 09, 2023

SELL
$30.02 - $38.81 $466,720 - $603,379
-15,547 Reduced 81.9%
3,436 $112,000
Q2 2023

Aug 11, 2023

SELL
$26.7 - $37.02 $898,027 - $1.25 Million
-33,634 Reduced 63.92%
18,983 $671,000
Q1 2023

May 12, 2023

BUY
$26.64 - $39.74 $1.21 Million - $1.81 Million
45,605 Added 650.39%
52,617 $1.49 Million
Q4 2022

Feb 08, 2023

BUY
$38.78 - $46.78 $201,229 - $242,741
5,189 Added 284.64%
7,012 $291,000
Q3 2022

Nov 10, 2022

BUY
$30.9 - $50.65 $31,610 - $51,814
1,023 Added 127.88%
1,823 $75,000
Q2 2022

Aug 10, 2022

SELL
$29.23 - $44.45 $576,006 - $875,931
-19,706 Reduced 96.1%
800 $26,000
Q1 2022

May 16, 2022

BUY
$16.89 - $35.74 $31,026 - $65,654
1,837 Added 9.84%
20,506 $718,000
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $444,079 - $835,627
18,052 Added 2925.77%
18,669 $467,000
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $22,156 - $25,876
617 New
617 $24,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.13B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.